By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Proposed Indian bills could oust elected officials jailed over 30 days, sparking opposition uproar. Critics fear misuse ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...